European experience of allogeneic hematopoietic stem cell transplantation for metastatic renal carcinoma: On behalf of the french ITAC group and the EBMT Solid ...
Missing: haematopoietic | Show results with:haematopoietic
Metastatic renal-cell carcinoma (RCC) is resistant to chemotherapy, and patients with this disease have a poor outlook. Immunotherapy by use of cytokines ...
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe. L. Barkholt, M. Bregni, M. Remberger, D. Blaise, J. Peccatori ...
Therefore, assessing the efficacy of allogeneic HSCT and its role for RCC is complex. Patients receiving HSCT have been highly selected and cannot simply be ...
Article: Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe.
Metastatic renal-cell carcinoma (RCC) remains resistant to nearly all standard cytotoxic therapies, but immune-based cytokine therapies benefit a small ...
Nov 16, 2012 · Graft versus Tumor (GvT) activity mediated by alloreactive donor T cells is being exploited in allogeneic HSCT also for the cure of advanced ...
Jan 9, 2024 · Herein, we overview the cellular therapies for RCC focusing on allogeneic hematopoietic stem cell transplantation, T cell receptor gene-modified ...
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe // Annals of Oncology. 2006. Vol. 17. No. 7. pp. 1134-1140 ...
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe.